Skip to main content

Table 1 Baseline characteristics of participants in NHANES III (1988–1994) according to weight change patterns from 10 years before the survey to baseline

From: Weigh change across adulthood is related to the presence of NAFLD: results from NHANES III

 

Stable nonobese

Obese to nonobese

P* value

Stable obese

Nonobese to obese

P# value

N = 3681

N = 260

N = 803

N = 937

NAFLD

728 (19.8)

71 (27.3)

0.005

386 (48.1)

395 (42.2)

0.015

 Age-adjusted NAFLD prevalence, %

19.84 (18.43–21.34)

28.20 (21.63–36.48)

 

47.73 (43.07–52.79)

42.37 (38.12–47.03)

 

 Age, years

56.14 (10.70)

60.13 (9.69)

 < 0.001

56.80 (10.10)

53.77 (10.09)

 < 0.001

 Female

1873 (50.9)

116 (44.6)

0.059

483 (60.1)

581 (62.0)

0.458

Race/ethnicity

 Non-hispanic white

794 (21.6)

88 (33.8)

 < 0.001

215 (26.8)

262 (28.0)

0.922

 Non-Hispanic black

767 (20.8)

73 (28.1)

 

228 (28.4)

258 (27.5)

 

 Mexican–American

1983 (53.9)

97 (37.3)

 

339 (42.2)

390 (41.6)

 

 Other

137 (3.7)

2 (0.8)

 

21 (2.6)

27 (2.9)

 

FIPR group

 < 1.3

717 (19.5)

90 (34.6)

 < 0.001

213 (26.5)

255 (27.2)

0.013

 1.3 to 3.5

1474 (40.0)

59 (22.7)

 

227 (28.3)

318 (33.9)

 

  ≥ 3.5

1490 (40.5)

111 (42.7)

 

363 (45.2)

364 (38.8)

 

Marital status

 Living with partner

2722 (74.0)

182 (70.5)

0.244

542 (67.8)

645 (69.1)

0.621

 Single

954 (26.0)

76 (29.5)

 

257 (32.2)

289 (30.9)

 

Health status

 Excellent or good

2842 (77.2)

141 (54.2)

 < 0.001

494 (61.5)

664 (70.9)

 < 0.001

 Fair

692 (18.8)

81 (31.2)

 

231 (28.8)

227 (24.2)

 

 Poor

147 (4.0)

38 (14.6)

 

78 (9.7)

46 (4.9)

 

 Waist circumference, cm

90.54 (9.67)

98.01 (8.18)

 < 0.001

114.60 (11.73)

107.79 (9.04)

 < 0.001

BMI, kg/m2

 BMI25

22.03 (2.86)

25.30 (4.49)

 < 0.001

27.28 (5.19)

23.45 (3.14)

 < 0.001

 BMI10prior

23.89 (2.88)

33.05 (3.93)

 < 0.001

35.13 (4.84)

26.59 (2.40)

 < 0.001

 BMIbaseline

24.97 (2.98)

27.57 (2.12)

 < 0.001

36.47 (5.54)

33.19 (3.11)

 < 0.001

 Diabetes

343 (9.3)

96 (36.9)

 < 0.001

272 (33.9)

148 (15.8)

 < 0.001

 Hypertension

1557 (42.3)

176 (67.7)

 < 0.001

527 (65.6)

535 (57.1)

 < 0.001

 Hypercholesterolemia

1512 (41.7)

125 (48.8)

0.03

335 (42.4)

412 (44.9)

0.318

 Current smoker

942 (25.6)

77 (29.6)

0.174

129 (16.1)

169 (18.0)

0.306

 TC, mg/dL

218.14 (42.08)

220.62 (45.36)

0.368

219.47 (42.09)

223.19 (45.59)

0.086

 TG, mg/dL

152.77 (118.83)

176.04 (113.99)

0.003

190.67 (146.32)

192.25 (141.29)

0.824

 LDL-C, mg/dL

136.78 (37.77)

138.82 (40.32)

0.572

138.72 (37.19)

139.04 (39.79)

0.912

 HDL-C, mg/dL

52.04 (16.30)

48.67 (16.78)

0.002

45.70 (12.76)

47.53 (14.24)

0.007

 LP(a), mg/dL

25.84 (28.25)

29.58 (30.90)

0.151

27.29 (31.31)

25.52 (28.91)

0.366

 CRP, mg/dL

0.21 [0.21, 0.40]

0.21 [0.21, 0.55]

0.002

0.44 [0.21, 0.90]

0.30 [0.21, 0.70]

 < 0.001

 HOMA-IR

1.86 [1.32, 2.84]

2.84 [1.83, 4.59]

 < 0.001

4.02 [2.66, 7.29]

3.41 [2.34, 5.17]

 < 0.001

 Fast glucose, mg/dL

100.85 (35.48)

128.22 (73.87)

 < 0.001

122.40 (59.46)

107.26 (41.79)

 < 0.001

 UA, mg/dL

5.25 (1.43)

5.58 (1.67)

0.001

5.83 (1.55)

5.79 (1.51)

0.565

 Creatinine, mg/dL

1.10 (0.33)

1.28 (1.14)

 < 0.001

1.10 (0.47)

1.08 (0.23)

0.331

 AST, U/L

21.35 (10.87)

20.16 (8.07)

0.091

21.06 (9.69)

23.21 (15.24)

0.001

 ALT, U/L

16.16 (12.17)

15.28 (8.90)

0.263

17.53 (10.36)

20.72 (15.71)

 < 0.001

 GGT, U/L

30.65 (36.11)

34.61 (34.64)

0.145

36.50 (37.42)

42.26 (66.60)

0.058

  1. Data are given as mean ± SD, n (%), or median [interquartile range] as appropriate
  2. *p-values were calculated for the comparison between stable non-obese and obese to non-obese NAFLD participants from age 25 years to baseline
  3. #p-values were calculated for the comparison between non-obese to obese and stable obese NAFLD participants from age 25 years to baseline
  4. NHANES national health and nutrition examination surveys, CI confidence interval, FPIR family poverty income ratio, BMI body mass index, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LP(a) Lipoprotein(a), CRP C-reactive protein, HOMA-IR homeostatic model assessment–insulin resistance, UA uric acid, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT γ-glutamyl transferase